SCHEMBL7863759

SCHEMBL7863759

OCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCO

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
THRB P10828 1/20 0.55
HTT P42858 1/20 0.55
MAPT P10636 1/20 0.55
GAA P10253 1/20 0.54
TSHR P16473 3/20 0.50
MAPK1 P28482 1/20 0.50
LMNA P02545 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
USP2 O75604 1/20 0.36
ACHE P22303 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL129274 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL9011790 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL841798 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL19860394 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL54120 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL8936938 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL9083002 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL6047745 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL21357398 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
SCHEMBL989676 1.00 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0483105-B2 Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers ORTHO MCNEIL PHARM INC (US) 2001-01-17 EP disclosed
EP-0272987-B1 RESILIENT TRANSDERMAL DRUG-DELIVERY DEVICE AND COMPOSITIONS AND DEVICES EMPLOYING FATTY ACID ESTERS/ETHERS OR ALKANEDIOLS AS PERCUTANEOUS ABSORPTION ENHANCERS CYGNUS THERAPEUTIC SYSTEMS (US) 1993-03-24 EP disclosed
EP-0272918-B1 DIFFUSION MATRIX FOR TRANSDERMAL DRUG ADMINISTRATION AND TRANSDERMAL DRUG DELIVERY DEVICES INCLUDING SAME CYGNUS THERAPEUTIC SYSTEMS (US) 1992-07-15 EP disclosed
EP-0483105-A1 Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers CYGNUS THERAPEUTIC SYSTEMS (US) 1992-04-29 EP disclosed
US-5006342-A Resilient transdermal drug delivery device CYGNUS CORPORATION (US) 1991-04-09 US disclosed
US-4911916-A Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same CYGNUS RESEARCH CORPORATION (US) 1990-03-27 US disclosed
US-4906463-A Transdermal drug-delivery composition CYGNUS RESEARCH CORPORATION (US) 1990-03-06 US disclosed
EP-0272918-A2 Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same CYGNUS THERAPEUTIC SYSTEMS (US) 1988-06-29 EP disclosed
EP-0272987-A2 Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers or alkanediols as percutaneous absorption enhancers CYGNUS THERAPEUTIC SYSTEMS (US) 1988-06-29 EP disclosed